HomeLYRA • NASDAQ
Lyra Therapeutics Inc
add
$0.092
0.65%
After Hours:(1.74%)-0.0016
$0.090
Closed: May 23, 6:08:02 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 183.00K | -65.60% |
Operating expense | 3.26M | -43.92% |
Net income | -8.55M | 61.93% |
Net profit margin | -4.67K | -10.67% |
Earnings per share | — | — |
EBITDA | -7.83M | 66.53% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.74M | -63.57% |
Total assets | 56.32M | -60.21% |
Total liabilities | 52.44M | -18.09% |
Total equity | 3.87M | — |
Shares outstanding | 66.27M | — |
Price to book | 1.54 | — |
Return on assets | -32.43% | — |
Return on capital | -47.81% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.55M | 61.93% |
Cash from operations | -8.84M | 60.62% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -8.84M | -48.51% |
Free cash flow | -5.02M | 65.94% |
Previous close
$0.092
Day range
$0.088 - $0.097
Year range
$0.082 - $0.34
Market cap
6.25M USD
Avg Volume
5.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2005
Headquarters
Website
Employees
30
